Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sheikh-Hamad

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2022
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axisRaghu Ganugula, Nikhil K Nuthalapati, Subhash Dwivedi, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2025
Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicityCole S Hudson, James E Smith, Linh T Vuong, et al.
Toxicology and Applied Pharmacology|September 6, 2025
Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicityCole S Hudson, James E Smith, Rongjin Sun, et al.
The American Journal of Pathology|February 28, 2009
Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritisLuping Huang, Gabriela Garcia, Yahuan Lou, et al.
Clinical and Experimental Medicine|April 10, 2021
Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational studyLi Tan, Yi Tang, Gai-Qin Pei, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathwayJenny Szu-Chin Pan, Luping Huang, Tatiana Belousova, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
AKI after conditional and kidney-specific knockdown of stanniocalcin-1Luping Huang, Tatiana Belousova, Jenny Szu-Chin Pan, et al.
Journal of the American Society of Nephrology : JASN|April 24, 2001
Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant miceYeong-Jin Choi, Leonardo Mendoza, Suk-Joo Rha, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2003
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2John Kanellis, Susumu Watanabe, Jin H Li, et al.
Investigative Ophthalmology & Visual Science|May 25, 2017
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of LatanoprostGavin W Roddy, Kimberly B Viker, Nelson S Winkler, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2022
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axisRaghu Ganugula, Nikhil K Nuthalapati, Subhash Dwivedi, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2025
Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicityCole S Hudson, James E Smith, Linh T Vuong, et al.
Toxicology and Applied Pharmacology|September 6, 2025
Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicityCole S Hudson, James E Smith, Rongjin Sun, et al.
The American Journal of Pathology|February 28, 2009
Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritisLuping Huang, Gabriela Garcia, Yahuan Lou, et al.
Clinical and Experimental Medicine|April 10, 2021
Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational studyLi Tan, Yi Tang, Gai-Qin Pei, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathwayJenny Szu-Chin Pan, Luping Huang, Tatiana Belousova, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
AKI after conditional and kidney-specific knockdown of stanniocalcin-1Luping Huang, Tatiana Belousova, Jenny Szu-Chin Pan, et al.
Journal of the American Society of Nephrology : JASN|April 24, 2001
Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant miceYeong-Jin Choi, Leonardo Mendoza, Suk-Joo Rha, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2003
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2John Kanellis, Susumu Watanabe, Jin H Li, et al.
Investigative Ophthalmology & Visual Science|May 25, 2017
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of LatanoprostGavin W Roddy, Kimberly B Viker, Nelson S Winkler, et al.
Pageof 6